Tevogen Inc.
TVGN
$7.34
$0.010.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.38M | 2.27M | 3.36M | 2.62M | 2.74M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.66M | 5.40M | 4.61M | 5.73M | 5.44M |
| Operating Income | -5.66M | -5.40M | -4.61M | -5.73M | -5.44M |
| Income Before Tax | -5.76M | -5.45M | -4.68M | -5.73M | -5.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.76M | -5.45M | -4.68M | -5.73M | -5.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.76M | -5.45M | -4.68M | -5.73M | -5.50M |
| EBIT | -5.66M | -5.40M | -4.61M | -5.73M | -5.44M |
| EBITDA | -5.63M | -5.37M | -4.55M | -5.73M | -5.35M |
| EPS Basic | -1.53 | -1.61 | -2.35 | -1.50 | -1.71 |
| Normalized Basic EPS | -0.94 | -0.98 | -1.42 | -0.91 | -1.04 |
| EPS Diluted | -1.53 | -1.61 | -2.35 | -1.50 | -1.71 |
| Normalized Diluted EPS | -0.94 | -0.98 | -1.42 | -0.91 | -1.04 |
| Average Basic Shares Outstanding | 3.83M | 3.49M | 2.05M | 3.92M | 3.29M |
| Average Diluted Shares Outstanding | 3.83M | 3.49M | 2.05M | 3.92M | 3.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |